The effect of dabigatran and rivarovaban on a prothrombinase-based assay for activated protein C resistance: a preliminary study in subjects heterozygous for factor V Leiden.
作者信息
Gessoni Gianluca, Valverde Sara, Gessoni Francesca, Valle Roberto
机构信息
Transfusion Service, "Madonna della Navicella" Hospital, Chioggia, Italy.
Laboratory Medicine, "Madonna della Navicella" Hospital, Chioggia, Italy.
出版信息
Blood Transfus. 2015 Oct;13(4):666-8. doi: 10.2450/2015.0224-14. Epub 2015 Jan 29.
Abstract
摘要
相似文献
1
The effect of dabigatran and rivarovaban on a prothrombinase-based assay for activated protein C resistance: a preliminary study in subjects heterozygous for factor V Leiden.
Blood Transfus. 2015 Oct;13(4):666-8. doi: 10.2450/2015.0224-14. Epub 2015 Jan 29.
2
Effect of dabigatran on a prothrombinase-based assay for detecting activated protein C resistance: an ex vivo and in vitro study in normal subjects and factor V Leiden carriers.
Blood Transfus. 2017 Oct;15(6):562-567. doi: 10.2450/2017.0199-16. Epub 2017 Mar 7.
3
Lack of rivaroxaban influence on a prothrombinase-based assay for the detection of activated C protein resistance: an Italian ex vivo and in vitro study in normal subjects and factor V Leiden carriers.
Int J Lab Hematol. 2017 Aug;39(4):418-422. doi: 10.1111/ijlh.12647. Epub 2017 Mar 20.
4
Rivaroxaban Causes Missed Diagnosis of Protein S Deficiency but Not of Activated Protein C Resistance (Factor V Leiden).
Arch Pathol Lab Med. 2018 Jan;142(1):70-74. doi: 10.5858/arpa.2016-0616-OA. Epub 2017 Sep 18.
5
Measurement and reversal of the direct oral anticoagulants.
Blood Rev. 2017 Jan;31(1):77-84. doi: 10.1016/j.blre.2016.08.006. Epub 2016 Sep 2.
6
[Not Available].
Lakartidningen. 2018 Dec 4;115:FDF4.
7
Apixaban Does Not Interfere With Protein S or Activated Protein C Resistance (Factor V Leiden) Testing Using aPTT-Based Methods.
Arch Pathol Lab Med. 2020 Nov 1;144(11):1401-1407. doi: 10.5858/arpa.2019-0497-OA.
8
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
Thromb Haemost. 2011 Feb;105(2):371-8. doi: 10.1160/TH10-06-0342. Epub 2010 Nov 23.
9
Perils in the thrombophilia workup: Frequency and circumstances of erroneously ordered factor V activity tests for thrombophilia.
Vasc Med. 2017 Dec;22(6):527-528. doi: 10.1177/1358863X17728122. Epub 2017 Sep 30.
10
Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests.
PLoS One. 2020 Oct 12;15(10):e0240483. doi: 10.1371/journal.pone.0240483. eCollection 2020.
引用本文的文献
1
Effect of dabigatran on a prothrombinase-based assay for detecting activated protein C resistance: an ex vivo and in vitro study in normal subjects and factor V Leiden carriers.
Blood Transfus. 2017 Oct;15(6):562-567. doi: 10.2450/2017.0199-16. Epub 2017 Mar 7.
本文引用的文献
1
The effect of dabigatran on select specialty coagulation assays.
Am J Clin Pathol. 2013 Jan;139(1):102-9. doi: 10.1309/AJCPY6G6ZITVKPVH.
2
Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature.
Thromb Res. 2012 Dec;130(6):956-66. doi: 10.1016/j.thromres.2012.09.004. Epub 2012 Sep 21.
3
Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
Thromb Haemost. 2012 May;107(5):985-97. doi: 10.1160/TH11-11-0804. Epub 2012 Mar 22.
4
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
Thromb Haemost. 2011 Feb;105(2):371-8. doi: 10.1160/TH10-06-0342. Epub 2010 Nov 23.
5
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.
J Thromb Haemost. 2011 Jan;9(1):133-9. doi: 10.1111/j.1538-7836.2010.04098.x.
6
Factor V Leiden in Chioggia: a prevalence study in patients with venous thrombosis, their blood relatives and the general population.
Blood Transfus. 2010 Jul;8(3):193-5. doi: 10.2450/2010.0157-09.
7
Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Blood Coagul Fibrinolysis. 2007 Oct;18(7):603-10. doi: 10.1097/MBC.0b013e3282891e2f.
8
Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
Minerva Med. 2007 Apr;98(2):89-93.
Zotero 插件